Iacopo Gesmundo

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Growth hormone-releasing hormone attenuates amyloid deposition and neuroinflammation in Alzheimer's disease models.

Growth hormone-releasing hormone attenuates amyloid deposition and neuroinflammation in Alzheimer's disease models.

Journal: Cell death & disease

Published: June 16, 2025

Publisher Correction: Growth hormone-releasing hormone and its analogues in health and disease.

Publisher Correction: Growth hormone-releasing hormone and its analogues in health and disease.

Journal: Nature reviews. Endocrinology

Published: December 16, 2024

Author Correction: Growth hormone-releasing hormone and its analogues in health and disease.

Author Correction: Growth hormone-releasing hormone and its analogues in health and disease.

Journal: Nature reviews. Endocrinology

Published: November 28, 2024

Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.

Growth Hormone-Releasing Hormone Antagonists Increase Radiosensitivity in Non-Small Cell Lung Cancer Cells.

Journal: International journal of molecular sciences

Published: November 19, 2024

Growth hormone-releasing hormone and its analogues in health and disease.

Growth hormone-releasing hormone and its analogues in health and disease.

Journal: Nature reviews. Endocrinology

Published: October 15, 2024

Growth hormone-releasing hormone and cancer.

Growth hormone-releasing hormone and cancer.

Journal: Reviews in endocrine & metabolic disorders

Published: October 14, 2024

Association between the use of proton pump inhibitors and serum PSA levels in the general U.S. population.

Association between the use of proton pump inhibitors and serum PSA levels in the general U.S. population.

Journal: World journal of urology

Published: July 21, 2024

Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study.

Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: August 21, 2023

Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.

Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells.

Journal: Frontiers in immunology

Published: May 30, 2023

Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice.

Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 05, 2023

Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.

Single-run UHPLC-MS/MS method for simultaneous quantification of endogenous steroids and their phase II metabolites in serum for anti-doping purposes.

Journal: Talanta

Published: October 25, 2022

Urinary Zinc Loss Identifies Prostate Cancer Patients.

Urinary Zinc Loss Identifies Prostate Cancer Patients.

Journal: Cancers

Published: August 29, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026